Fort Lauderdale, Fla. (PRWEB) April 10, 2013
Lenyosys, a division of Nestatek Inc., headquartered in Fort Lauderdale, Fl., announced today that it will be premiering its North America portfolio of LENYO advanced Bioregulation Therapy (BRT) devices at the American Academy of Anti-Aging Medicine (A4M) World Congress in Orlando, Fla., April 11-14.
BRT is a proven, holistic approach to health and wellness which addresses the body at the cellular level. During a BRT session, safe, non-invasive electromagnetic field devices generate low intensity Pulsed Electromagnetic Field (PEMF) signals that stimulate cells and restore biological communication paths in order to induce the body’s natural healing process. It is the body’s own self-regulation process that improves or eliminates difficulties and disabling symptoms in cells, tissues and organs – caused by a number of factors including aging, nutrition, stress or the environment.
“Regular tuning up of our cells is not only feasible, but necessary to slow aging and reduce the risk of cell dysfunction and disease,” says Dr. William Pawluk, MD, MSc., author, researcher and national medical expert on electromagnetic field therapy. “PEMF-based therapy has been in use for decades, and the addition of the LENYO line of electromagnetic field devices into the North America market is a great stride in broadening access to this valuable health and wellness therapy with both professional practitioners and the general public.”
Already a leading product in Europe for over 15 years, LENYO BRT devices utilize a state-of-the-art signaling capability that is unique to the industry. Through frequency, intensity, modulation and customized programming, these devices are able to precisely stimulate and fine-tune the exact communication receptors associated with the natural healing process of the targeted area. By combining this precision BRT technology with the body’s own inner communication processes, LENYO BRT devices help the body to accelerate healing and maintain overall wellness.
LENYO BRT devices are available in a variety of size and feature options – from professional multi-user systems to pocket-size, mobile devices that can be used in the home, at the office or on-the-go – and they offer more than 660 automated programs specific to conditions and imbalances across all the major systems of the body.
“I’m excited to bring this new product line to the NA market,” says Turul Sengul, President, of Lenyosys “With the broadest range of BRT device choices in the industry, the LENYO advanced BRT product portfolio is based on the true synergy of technology and nature. Whether used alone or as a complement to another therapy approach, I am confident that today’s integrative health and wellness practitioners will find each of the LENYO BRT devices to be a valuable contribution to the pursuit of overall health and better quality of life for their patients.”
Lenyosys will be introducing the complete LENYO line of BRT devices in the North America market for the first time at the A4M event. Visitors to the Lenyosys booth (#931) will have the opportunity to see all of the LENYO products, as well as experience a hands-on demonstration of two signature devices – the professional-use LENYO CellCom that offers more than 550 automated BRT programs, and the LENYO SanoCenter, an advanced, centrally-managed therapy system.
Lenyosys will also be showcasing the LENYO BRT devices at the American Holistic Medical Association (AHMA) Gateway Medical Conference in St. Louis, April 17-21.
A leader in bioregulation technology and devices, Lenyosys™, a division of Nestatek Inc., headquartered in Fort Lauderdale, Fla., provides advanced BRT devices and solutions to professional practitioners in the medical, wellness, sports, enterprise, educational and veterinarian fields, as well as home-use products to the general public. Based on state-of-the-art signaling technology, the LENYO line of BRT products include office, in-home and mobile devices. For more information, visit http://www.lenyosys.com.
LENYO BRT devices have not been evaluated by The Food and Drug Administration (FDA). They are not meant to diagnose, treat, cure or prevent any disease. Individuals suffering from any disease or illness should consult with a physician or healthcare professional before using any BRT device.
# # #